Brooke M. Emerling

5.4k citations

36 papers · 2.1k indexed · h-index 20

Co-authors: Navdeep S. Chandel Stéphane J. H. Ricoult Leonard Guarente Frank Weinberg Benoı̂t Viollet Eric L. Bell Ángel R. Nebreda Juinn-Lin Liu
Topics: Cancer, Hypoxia, and Metabolism (11 papers)Mitochondrial Function and Pathology (5 papers)PI3K/AKT/mTOR signaling in cancer (5 papers)
Cited by: Geriatrics and Gerontology Cancer Research Physiology
Journals: Cell Proceedings of the National Academy of Sciences Nature reviews. Cancer
Partner nations: United States Switzerland Israel

In The Last Decade

Brooke M. Emerling

35 papers receiving 2.1k citations

Peers

Countries citing papers authored by Brooke M. Emerling

Since Specialization

Citations

This map shows the geographic impact of Brooke M. Emerling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brooke M. Emerling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brooke M. Emerling more than expected).

Fields of papers citing papers by Brooke M. Emerling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brooke M. Emerling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brooke M. Emerling. The network helps show where Brooke M. Emerling may publish in the future.

Co-authorship network of co-authors of Brooke M. Emerling

This figure shows the co-authorship network connecting the top 25 collaborators of Brooke M. Emerling. A scholar is included among the top collaborators of Brooke M. Emerling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brooke M. Emerling. Brooke M. Emerling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP 2024 ·Science Signaling ·Lavinia Palamiuc,Jared L. Johnson,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Archna Ravi,Thorsten Wiederhold,Rabi Murad,Raymond D. Blind,Brooke M. Emerling	5
2	Activation of p53-regulated pro-survival signals and hypoxia-independent mitochondrial targeting of TIGAR by human papillomavirus E6 oncoproteins 2023 ·Virology ·(unknown),(unknown),(unknown),(unknown),Kylie R. James,(unknown),(unknown),Brenda Y. Hernandez,Brooke M. Emerling,(unknown),Robert Harrod	7
3	Endogenous spacing enables co-processing of microRNAs and efficient combinatorial RNAi 2022 ·Cell Reports Methods ·Alexandra M. Amen,(unknown),Chun‐Hao Huang,Rachel J. Lew,Archna Ravi,(unknown),Emma M. Schatoff,Lukas E. Dow,Brooke M. Emerling,Christof Fellmann	8
4	Beyond PI3Ks: targeting phosphoinositide kinases in disease 2022 ·Nature Reviews Drug Discovery ·John E. Burke,Joanna Triscott,Brooke M. Emerling,Gerald Hammond	77
5	PIP kinases: A versatile family that demands further therapeutic attention 2022 ·Advances in Biological Regulation ·(unknown),(unknown),(unknown),Brooke M. Emerling	5
6	A Functional Precision Oncology Approach to Identify Treatment Strategies for Myxofibrosarcoma Patients 2021 ·Zurich Open Repository and Archive (University of Zurich) ·Chantal Pauli,(unknown),(unknown),(unknown),Lara Planas‐Paz,Reid Shaw,Brooke M. Emerling,Carla Grandori,Benjamin D. Hopkins,Mark A. Rubin	5
7	Mechanistic roles of mutant p53 governing lipid metabolism 2021 ·Advances in Biological Regulation ·(unknown),Brooke M. Emerling	13
8	Fenofibrate prevents skeletal muscle loss in mice with lung cancer 2018 ·Proceedings of the National Academy of Sciences ·Marcus D. Goncalves,Seo‐Kyoung Hwang,Chantal Pauli,Charles J. Murphy,Zhe Cheng,Benjamin D. Hopkins,David Wu,(unknown),Brooke M. Emerling,Guoan Zhang,Douglas T. Fearon,Lewis C. Cantley	85
9	Deletion of the gene Pip4k2c , a novel phosphatidylinositol kinase, results in hyperactivation of the immune system 2016 ·Proceedings of the National Academy of Sciences ·Hyeseok Shim,Chuan Wu,(unknown),Kaitlyn Bosch,Zuojia Chen,Brooke M. Emerling,Jihye Yun,Hui Liu,Rayman Choo-Wing,Zhiwei Yang,Gerburg M. Wulf,Vijay K. Kuchroo,Lewis C. Cantley	48
10	Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null Tumors 2013 ·Cell ·Brooke M. Emerling,Jonathan Hurov,George Poulogiannis,(unknown),Rayman Choo-Wing,Gerburg M. Wulf,Eric L. Bell,Hyeseok Shim,Katja Lamia,Lucia E. Rameh,Gary Bellinger,Atsuo T. Sasaki,John M. Asara,Xin Yuan,Andrea J. Bullock,Gina M. DeNicola,Jiaxi Song,Victoria E. Brown,Sabina Signoretti,Lewis C. Cantley	144
11	A Homogeneous, High-Throughput Assay for Phosphatidylinositol 5-Phosphate 4-Kinase with a Novel, Rapid Substrate Preparation 2013 ·PLoS ONE ·Mindy I. Davis,Atsuo T. Sasaki,Min Shen,Brooke M. Emerling,Natasha Thorne,Sam Michael,Rajan Pragani,Matthew B. Boxer,Kazutaka Sumita,Koh Takeuchi,Douglas S. Auld,Zhuyin Li,Lewis C. Cantley,Anton Simeonov	42
12	Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients 2013 ·Proceedings of the National Academy of Sciences ·Brooke M. Emerling,Cyril H. Benes,George Poulogiannis,Eric L. Bell,Kevin D. Courtney,Hui Liu,Rayman Choo-Wing,Gary Bellinger,(unknown),Victoria E. Brown,Sabina Signoretti,Stephen P. Soltoff,Lewis C. Cantley	49
13	Emerging concepts: linking hypoxic signaling and cancer metabolism 2012 ·Cell Death and Disease ·Costas A. Lyssiotis,(unknown),Cristina Muñoz‐Pinedo,Brooke M. Emerling	16
14	Targeting PI3K/mTOR Signaling in Cancer 2011 ·Cancer Research ·Brooke M. Emerling,Argun Akçakanat	31
15	SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production 2011 ·DSpace@MIT (Massachusetts Institute of Technology) ·Brooke M. Emerling,Stéphane J. H. Ricoult,(unknown),Leonard Guarente	372
16	SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production 2011 ·Oncogene ·Eric L. Bell,Brooke M. Emerling,Stéphane J. H. Ricoult,Leonard Guarente	4
17	Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio 2009 ·Free Radical Biology and Medicine ·Brooke M. Emerling,Frank Weinberg,Colleen M. Snyder,(unknown),Gökhan M. Mutlu,Benoı̂t Viollet,G. R. Scott Budinger,Navdeep S. Chandel	278
18	Compound C inhibits hypoxic activation of HIF‐1 independent of AMPK 2007 ·FEBS Letters ·Brooke M. Emerling,Benoı̂t Viollet,Kathryn V. Tormos,Navdeep S. Chandel	87
19	Oxygen Sensing: Getting Pumped by Sterols 2005 ·Science s STKE ·Brooke M. Emerling,Navdeep S. Chandel	14
20	Isolation and analysis of candidate myeloid tumor suppressor genes from a commonly deleted segment of 7q22 2005 ·Genomics ·(unknown),Jeannette M. Bonifas,Jennifer Lauchle,(unknown),Christian P. Kratz,Brooke M. Emerling,Eric D. Green,Michelle M. Le Beau,Kevin Shannon	37

About Brooke M. Emerling

Brooke M. Emerling is a scholar working on Cancer Research, Cell Biology and Hematology, having authored 36 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (11 papers), Mitochondrial Function and Pathology (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). The work is most often cited by research in Geriatrics and Gerontology (238 citations), Cancer Research (559 citations) and Physiology (111 citations). Brooke M. Emerling has collaborated with scholars based in United States, Switzerland and Israel. Frequent co-authors include Navdeep S. Chandel, Stéphane J. H. Ricoult, Leonard Guarente, Frank Weinberg, Benoı̂t Viollet, Eric L. Bell, Ángel R. Nebreda, Juinn-Lin Liu, Leonidas C. Platanias and Tak W. Mak. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature reviews. Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact